9 selected records with a cited source date in 2001. This archive is selective and does not imply continuous monitoring or complete historical coverage.
The official Drugs@FDA dataset lists original submission 1 for ANDA 075721 with status AP dated 2001-11-29, and names leuprolide acetate among the application record's active ingredients.
The official Drugs@FDA dataset lists original submission 1 for NDA 020920 with status AP dated 2001-08-10, and names nesiritide among the application record's active ingredients.
The official Drugs@FDA dataset lists original submission 1 for NDA 021288 with status AP dated 2001-06-29, and names triptorelin pamoate among the application record's active ingredients.
The Federal Register published notice 01-14410, attributed to FDA and its parent HHS department, on 2001-06-08. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committe; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Pramlintide and Teriparatide.
The Federal Register published notice 01-11620, attributed to FDA and its parent HHS department, on 2001-05-09. Its official title is “Purina Mills, Inc., et al.; Withdrawal of Approval of New Animal Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.
The Federal Register published rule 01-11621, attributed to FDA and its parent HHS department, on 2001-05-09. Its official title is “Animal Drugs, Feeds, and Related Products; Trichlorfon, etc.; Withdrawal of Approval of NADAs,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.
The Federal Register published rule 01-11070, attributed to FDA and its parent HHS department, on 2001-05-03. Its official title is “Animal Drugs, Feeds, and Related Products; Tylosin Tartrate for Injection, etc.; Withdrawal of Approval of NADAs,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.
The Federal Register published notice 01-11071, attributed to FDA and its parent HHS department, on 2001-05-03. Its official title is “Elanco Animal Health, A Div. of Eli Lilly & Co. et al.; Withdrawal of Approval of NADAs,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.
The Federal Register published notice 01-10450, attributed to FDA and its parent HHS department, on 2001-04-27. Its official title is “Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Nesiritide.